Share Us: Subscribe | Contact

Biblio

Export 172 results:

Tagged

Filters: First Letter Of Last Name is X [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

E

Y. Xu, Vasiljevic, E., Deming, Y. K., Jonaitis, E. M., Koscik, R. L., Van Hulle, C. A., Lu, Q., Carboni, M., Kollmorgen, G., Wild, N., Carlsson, C. M., Johnson, S. C., Zetterberg, H., Blennow, K., and Engelman, C. D., “Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1587-1605, 2023.

D. Asaoka, Xiao, J., Takeda, T., Yanagisawa, N., Yamazaki, T., Matsubara, Y., Sugiyama, H., Endo, N., Higa, M., Kasanuki, K., Ichimiya, Y., Koido, S., Ohno, K., Bernier, F., Katsumata, N., Nagahara, A., Arai, H., Ohkusa, T., and Sato, N., “Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 88, no. 1, pp. 75-95, 2022.

J. Lyu, Zhang, J., Mu, H., Li, W., Champ, M., Xiong, Q., Gao, T., Xie, L., Jin, W., Yang, W., Cui, M., Gao, M., and Li, M., “The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1347-1358, 2018.

J. Lyu, Zhang, J., Mu, H., Li, W., Champ, M., Xiong, Q., Gao, T., Xie, L., Jin, W., Yang, W., Cui, M., Gao, M., and Li, M., “The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1347-1358, 2018.

T. A. Lansdell, Xu, H., Galligan, J. J., and Dorrance, A. M., “Effects of Striatal Amyloidosis on the Dopaminergic System and Behavior: A Comparative Study in Male and Female 5XFAD Mice.”, J Alzheimers Dis, vol. 94, no. 4, pp. 1361-1375, 2023.

G. Liu, Weinger, J. G., Lu, Z. - L., Xue, F., and Sadeghpour, S., “Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.”, J Alzheimers Dis, vol. 49, no. 4, pp. 971-90, 2016.

B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.

B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.

B. Xie, Xu, Y., Liu, Z., Liu, W., Jiang, L., Zhang, R., Cui, D., Zhang, Q., and Xu, S., “Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.”, J Alzheimers Dis, vol. 56, no. 1, pp. 391-401, 2017.

M. T. White, Shaw, L. M., and Xie, S. X., “Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.

H. Liang, Yin, X., Chen, T., Zhang, Y., Zhang, Q., Lin, J., Yin, H., Tang, J., He, Y., Xia, P., Zhu, Y., Li, H., Mo, Y., Li, Y., Wang, Y., Yang, X., and Hu, Z., “Excessive Sedentary Time Is Associated with Cognitive Decline in Older Patients with Minor Ischemic Stroke.”, J Alzheimers Dis, vol. 96, no. 1, pp. 173-181, 2023.

Y. Lian, Xiao, L. Dongxia, Zeng, F., Wu, X., Wang, Z., and Ren, H., “The Experiences of People with Dementia and Their Caregivers in Dementia Diagnosis.”, J Alzheimers Dis, vol. 59, no. 4, pp. 1203-1211, 2017.

A. Katrine Bergland, Proitsi, P., Kirsebom, B. - E., Soennesyn, H., Hye, A., Larsen, A. Inge, Xu, J., Legido-Quigley, C., Rajendran, L., Fladby, T., and Aarsland, D., “Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 77, no. 3, pp. 1117-1127, 2020.

G

W. Zhang, Guo, Y., Li, B., Zhang, Q., Liu, J. - H., Gu, G. - J., Wang, J. - H., Bao, R. - K., Chen, Y. - J., and Xu, J. - R., “GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 62, no. 2, pp. 807-819, 2018.

Y. - C. Xie, Yao, Z. - H., Yao, X. - L., Pan, J. - Z., Zhang, S. - F., Zhang, Y., and Hu, J. - C., “Glucagon-Like Peptide-2 Receptor is Involved in Spatial Cognitive Dysfunction in Rats After Chronic Cerebral Hypoperfusion.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1559-1576, 2018.

W. Xia, Luo, Y., Chen, Y. - C., Chen, H., Ma, J., and Yin, X., “Glucose Fluctuations Are Linked to Disrupted Brain Functional Architecture and Cognitive Impairment.”, J Alzheimers Dis, vol. 74, no. 2, 2020.

J. Spiegel, Pirraglia, E., Osorio, R. S., Glodzik, L., Li, Y., Tsui, W., Louis, L. A. Saint, Randall, C., Butler, T., Xu, J., Zinkowski, R. P., Zetterberg, H., Fortea, J., Fossati, S., Wisniewski, T., Davies, P., Blennow, K., and de Leon, M. J., “Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 93-100, 2016.

D. Chu, Tan, J., Xie, S., Jin, N., Yin, X., Gong, C. - X., Iqbal, K., and Liu, F., “GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner.”, J Alzheimers Dis, vol. 49, no. 2, pp. 365-75, 2016.

M. Guo, Peng, J., Huang, X., Xiao, L., Huang, F., and Zuo, Z., “Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 80, no. 1, pp. 299-310, 2021.

B. - L. Sun, Li, W. - W., Wang, J., Xu, Y. - L., Sun, H. - L., Tian, D. - Y., Wang, Y. - J., and Yao, X. - Q., “Gut Microbiota Alteration and Its Time Course in a Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 70, no. 2, pp. 399-412, 2019.

H. Ni, Xu, M., Zhan, G. - L., Fan, Y., Zhou, H., Jiang, H. - Y., Lu, W. - H., Tan, L., Zhang, D. - F., Yao, Y. - G., and Zhang, C., “The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1149-1161, 2018.

S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.

S. Shi, Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., and Qiao, Z., “Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways.”, J Alzheimers Dis, vol. 50, no. 3, pp. 859-71, 2016.

H

C. Chen, Zhang, H., Xu, H., Xue, R., Zheng, Y., Wu, T., and Lian, Y., “Harpagoside Rescues the Memory Impairments in Chronic Cerebral Hypoperfusion Rats by Inhibiting PTEN Activity.”, J Alzheimers Dis, vol. 63, no. 2, pp. 445-455, 2018.

C. Chen, Zhang, H., Xu, H., Xue, R., Zheng, Y., Wu, T., and Lian, Y., “Harpagoside Rescues the Memory Impairments in Chronic Cerebral Hypoperfusion Rats by Inhibiting PTEN Activity.”, J Alzheimers Dis, vol. 63, no. 2, pp. 445-455, 2018.

Pages